Characterization of human and rodent native and recombinant adenosine A2B receptors by radioligand binding studies

被引:21
作者
Bertarelli D.C.G. [1 ]
Diekmann M. [1 ]
Hayallah A.M. [1 ]
Rüsing D. [2 ]
Iqbal J. [1 ]
Preiss B. [1 ]
Verspohl E.J. [2 ]
Müller C.E. [3 ]
机构
[1] Pharmaceutical Institute, Pharmaceutical Sciences Bonn (PSB), University of Bonn, Bonn
[2] Institute of Pharmaceutical and Medicinal Chemistry, Department of Pharmacology, University of Münster, Münster
[3] Pharmazeutisches Institut, Pharmazeutische Chemie Poppelsdorf, Bonn 53115
关键词
[!sup]3[!/sup]H]PSB-298; A[!sub]2B[!/sub] antagonist radioligand; Adenosine A[!sub]2B[!/sub] receptor; CHO cells; HEK-293; cells; INS-1; NG108-15; Sodium shift assays;
D O I
10.1007/s11302-006-9012-4
中图分类号
学科分类号
摘要
Adenosine A2B receptors of native human and rodent cell lines were investigated using [3H]PSB-298 [(8-{4-[2-(2-hydroxyethylamino)-2-oxoethoxy]phenyl}-1-propylxanthine] in radioligand binding studies. [3H]PSB-298 showed saturable and reversible binding. It exhibited a KD value of 60 ± 1 nM and limited capacity (Bmax = 3.511 fmol per milligram protein) at recombinant human adenosine A2B receptors expressed in human embryonic kidney cells (HEK-293). The addition of sodium chloride (100 mM) led to a threefold increase in the number of binding sites recognized by the radioligand. The curve of the agonist 5′-N-ethylcarboxamidoadenosine (NECA) was shifted to the right in the presence of NaCl, while the curve of the antagonist PSB-298 was shifted to the left, indicating that PSB-298 may be an inverse agonist at A2B receptors. Adenosine A2B receptors were shown to be the major adenosine A2 receptor subtype on the mouse neuroblastoma x rat glioma hybrid cell line NG108-15 cells. Binding studies at rat INS-1 cells (insulin secreting cell line) demonstrated that [3H]PSB-298 is a selective radioligand for adenosine A2B binding sites in this cell line. © Springer Science + Business Media B.V. 2006.
引用
收藏
页码:559 / 571
页数:12
相关论文
共 25 条
  • [21] Pharmacological characterization of mitogen-activated protein kinase activation by recombinant human 5-HT2C, 5-HT2A, and 5-HT2B receptors
    Knauer, Christopher S.
    Campbell, Jeffrey E.
    Chio, Christopher L.
    Fitzgerald, Lawrence W.
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2009, 379 (05) : 461 - 471
  • [22] Functional and molecular characterization of kinin B1 and B2 receptors in human bladder cancer: implication of the PI3Kγ pathway
    Sgnaolin, V.
    Pereira, T. C. B.
    Bogo, M. R.
    Zanin, R.
    Battastini, A. M. O.
    Morrone, F. B.
    Campos, M. M.
    INVESTIGATIONAL NEW DRUGS, 2013, 31 (04) : 812 - 822
  • [23] Cross-reactivity of mouse IgG subclasses to human Fc gamma receptors: Antibody deglycosylation only eliminates IgG2b binding
    Temming, A. Robin
    Bentlage, Arthur E. H.
    de Taeye, Steven W.
    Bosman, Gerlof P.
    Lissenberg-Thunnissen, Suzanne N.
    Derksen, Ninotska I. L.
    Brasser, Giso
    Mok, Juk Yee
    van Esch, Wim J. E.
    Howie, Heather L.
    Zimring, James C.
    Vidarsson, Gestur
    MOLECULAR IMMUNOLOGY, 2020, 127 : 79 - 86
  • [24] Toll like receptors TLR1/2, TLR6 and MUC5b as binding interaction partners with cytostatic proline rich polypeptide 1 in human chondrosarcoma
    Galoian, Karina
    Abrahamyan, Silva
    Chailyan, Gor
    Qureshi, Amir
    Patel, Parthik
    Metser, Gil
    Moran, Alexandra
    Sahakyan, Inesa
    Tumasyan, Narine
    Lee, Albert
    Davtyan, Tigran
    Chailyan, Samvel
    Galoyan, Armen
    INTERNATIONAL JOURNAL OF ONCOLOGY, 2018, 52 (01) : 139 - 154
  • [25] CHARACTERIZATION OF BRADYKININ-B(2) RECEPTORS ON HUMAN IMR-90 LUNG FIBROBLASTS - STIMULATION OF CA-45(2+) EFFLUX BY D-PHE(7) SUBSTITUTED BRADYKININ ANALOGS
    SAWUTZ, DG
    FAUNCE, DM
    HOUCK, WT
    HAYCOCK, D
    EUROPEAN JOURNAL OF PHARMACOLOGY-MOLECULAR PHARMACOLOGY SECTION, 1992, 227 (03): : 309 - 315